Montpellier, France

Pierre Carayon

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Sanofi-Aventis. Active years: 2009-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pierre Carayon. Retrieved from https://idiyas.com/inventor/pierre-carayon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 2009-2010

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Pierre Carayon

Introduction

Pierre Carayon is a notable inventor based in Montpellier, France. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on thiazole derivatives. With a total of 2 patents, Carayon's inventions have the potential to impact therapeutic applications significantly.

Latest Patents

Carayon's latest patents focus on 2-acylamino-4-phenylthiazole derivatives. These inventions relate to compounds of general formula (I), which include pharmaceutically acceptable acid-addition salts, hydrates, or solvates of such derivatives. The patents also cover intermediates, processes for preparation, and therapeutic applications of these compounds. This work highlights Carayon's commitment to advancing pharmaceutical science.

Career Highlights

Throughout his career, Pierre Carayon has worked with prominent companies in the pharmaceutical industry, including Sanofi and Sanofi-Aventis. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to the advancement of medical treatments.

Collaborations

Carayon has collaborated with several notable professionals in his field, including Pierre Casellas and Daniel Floutard. These collaborations have likely enriched his work and expanded the impact of his inventions.

Conclusion

Pierre Carayon's contributions to the field of pharmaceuticals through his innovative patents demonstrate his expertise and dedication to improving therapeutic applications. His work continues to influence the industry and showcases the importance of innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…